OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of liver fibrosis biomarkers with overall and CVD mortality in the Korean population: The Dong-gu study
Seong-Woo Choi, Sun‐Seog Kweon, Young Hoon Lee, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0277729-e0277729
Open Access | Times Cited: 11
Seong-Woo Choi, Sun‐Seog Kweon, Young Hoon Lee, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0277729-e0277729
Open Access | Times Cited: 11
Showing 11 citing articles:
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population
Young‐Gyun Seo, Stergios A. Pοlyzos, Kyung‐Hee Park, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 13, pp. 3322-3335
Closed Access | Times Cited: 22
Young‐Gyun Seo, Stergios A. Pοlyzos, Kyung‐Hee Park, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 13, pp. 3322-3335
Closed Access | Times Cited: 22
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Amedeo Lonardo, Stefano Ballestri, György Baffy, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 5
Amedeo Lonardo, Stefano Ballestri, György Baffy, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 5
Association Between Noninvasive Liver Fibrosis Scores and Heart Failure in a General Population
Xiao Liu, H T Zhang, Cindy X. Fang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 22
Open Access | Times Cited: 4
Xiao Liu, H T Zhang, Cindy X. Fang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 22
Open Access | Times Cited: 4
Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008
Lihua Guan, Lei Li, Yutong Zou, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Lihua Guan, Lei Li, Yutong Zou, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress
Erika Minetti, Naomi M. Hamburg, Reiko Matsui
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Erika Minetti, Naomi M. Hamburg, Reiko Matsui
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
The liver fibrosis‐8 index is a predictor for all‐cause mortality in cardiovascular disease patients: A cohort study
Xian Yang, Jiaxin Wang, Xiaofang Zhang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 12, pp. 5971-5981
Closed Access | Times Cited: 2
Xian Yang, Jiaxin Wang, Xiaofang Zhang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 12, pp. 5971-5981
Closed Access | Times Cited: 2
Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment
Hua Liu, Yang-Min Hao, Sheng Jiang, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2613-2625
Open Access | Times Cited: 1
Hua Liu, Yang-Min Hao, Sheng Jiang, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2613-2625
Open Access | Times Cited: 1
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans‐Michael Steffen
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 390-393
Open Access | Times Cited: 3
Philipp Kasper, Münevver Demir, Hans‐Michael Steffen
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 390-393
Open Access | Times Cited: 3
Biomarkers of Hepatic Dysfunction and Cardiovascular Risk
Terence B. Lee, Martin Tze Wah Kueh, Vardhmaan Jain, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 12, pp. 1783-1795
Closed Access | Times Cited: 3
Terence B. Lee, Martin Tze Wah Kueh, Vardhmaan Jain, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 12, pp. 1783-1795
Closed Access | Times Cited: 3
Association between liver fibrosis and decreased myocardial mechano-energetic efficiency in individuals with different degree of glucose tolerance
Alessia Riccio, Camilla Mazzanti, Laura Vero, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110639-110639
Open Access | Times Cited: 1
Alessia Riccio, Camilla Mazzanti, Laura Vero, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110639-110639
Open Access | Times Cited: 1
Assessment of the risk of developing liver fibrosis in patients with non-alcoholic fatty liver disease
М. М. Арапханова, В. Б. Гриневич, Ю. А. Кравчук, et al.
Vrach (2023) Vol. 34, Iss. 6, pp. 55-58
Closed Access
М. М. Арапханова, В. Б. Гриневич, Ю. А. Кравчук, et al.
Vrach (2023) Vol. 34, Iss. 6, pp. 55-58
Closed Access
